ResearchMoz added Latest Research Report titled " Global Market Study on UCB Banking: Asia-Pacific to Witness Highest Growth by 2020 " to it's Large Report database.
Umbilical cord blood (UCB) is collected from the umbilical cord of a newborn baby and also retrieved from the placenta after delivery. It is enriched with adult stem cells and these stem cells play a vital role in regulating all biological activities and in developing tissues in the human body. Many types of stem cells are present in UCB including hematopoietic stem cells and mesenchymal stem cells. Hematopoietic stem cells give rise to all the other blood cells. Hematopoietic stem cells are severely damaged in people suffering from bone marrow diseases, malignancies, inherited metabolic disorders, and immunological disorders. Mesenchymal stem cells are involved in the development of tissues such as cartilage, bone, fat, new blood vessels, and cardiac muscles.
Browse full report discription @ http://www.researchmoz.us/global-market-study-on-ucb-banking-asia-pacific-to-witness-highest-growth-by-2020-report.html
UCB is used in clinical procedures associated with regenerative medicines. For instance, UCB-derived stem cells are used in hematopoietic stem cell transplantation (HSCT) for the treatment of life-threatening diseases such as leukemia and type I diabetes in children and adults. In addition, UCB is also used in the treatment of diseases such as bone marrow disorders, circulatory diseases, heart problems, neurological diseases, and cartilage disorders.
Globally, increasing prevalence of chronic diseases coupled with the emerging field of regenerative medicines is driving the UCB banking market. In addition, various government associations and initiatives are also supporting in the growth of the UCB banking market.
However, strict license and accreditation procedures impede the growth of UCB banking market. In addition, high banking cost in private UCB banks is also hampering the growth of UCB banking market. Allogeneic hematopoietic stem cell transplantation and cord tissue storage are some of the major trends in UCB banking market.
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Report Methodology
1.3 Assumptions
Chapter 2 Market Synopsis
Chapter 3 Porters Five Forces Analysis
3.1 Bargaining Power of Suppliers
3.2 Bargaining Power of Buyers
3.3 Threat of New Entrants
3.4 Threat of Substitutes
3.5 Intensity of Rivalry
Chapter 4 Industry overview
4.1 Market Definition
4.2 Market Drivers
4.2.1 Increasing prevalence of chronic diseases enhances the market growth
4.2.2 Emerging field of regenerative medicines boost the market growth
4.2.3 Initiatives by various government associations have increased the importance of UCB
4.3 Impact Analysis of Market Drivers
4.4 Market Restraints
4.4.1 Strict license and accreditation procedures impede the market growth
4.4.2 High cord blood banking fee in private UCB banks
4.5 Impact Analysis of Market Restraints
.
.
.
Browse more details with complete TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=320897
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Umbilical cord blood (UCB) is collected from the umbilical cord of a newborn baby and also retrieved from the placenta after delivery. It is enriched with adult stem cells and these stem cells play a vital role in regulating all biological activities and in developing tissues in the human body. Many types of stem cells are present in UCB including hematopoietic stem cells and mesenchymal stem cells. Hematopoietic stem cells give rise to all the other blood cells. Hematopoietic stem cells are severely damaged in people suffering from bone marrow diseases, malignancies, inherited metabolic disorders, and immunological disorders. Mesenchymal stem cells are involved in the development of tissues such as cartilage, bone, fat, new blood vessels, and cardiac muscles.
Browse full report discription @ http://www.researchmoz.us/global-market-study-on-ucb-banking-asia-pacific-to-witness-highest-growth-by-2020-report.html
UCB is used in clinical procedures associated with regenerative medicines. For instance, UCB-derived stem cells are used in hematopoietic stem cell transplantation (HSCT) for the treatment of life-threatening diseases such as leukemia and type I diabetes in children and adults. In addition, UCB is also used in the treatment of diseases such as bone marrow disorders, circulatory diseases, heart problems, neurological diseases, and cartilage disorders.
Globally, increasing prevalence of chronic diseases coupled with the emerging field of regenerative medicines is driving the UCB banking market. In addition, various government associations and initiatives are also supporting in the growth of the UCB banking market.
However, strict license and accreditation procedures impede the growth of UCB banking market. In addition, high banking cost in private UCB banks is also hampering the growth of UCB banking market. Allogeneic hematopoietic stem cell transplantation and cord tissue storage are some of the major trends in UCB banking market.
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Report Methodology
1.3 Assumptions
Chapter 2 Market Synopsis
Chapter 3 Porters Five Forces Analysis
3.1 Bargaining Power of Suppliers
3.2 Bargaining Power of Buyers
3.3 Threat of New Entrants
3.4 Threat of Substitutes
3.5 Intensity of Rivalry
Chapter 4 Industry overview
4.1 Market Definition
4.2 Market Drivers
4.2.1 Increasing prevalence of chronic diseases enhances the market growth
4.2.2 Emerging field of regenerative medicines boost the market growth
4.2.3 Initiatives by various government associations have increased the importance of UCB
4.3 Impact Analysis of Market Drivers
4.4 Market Restraints
4.4.1 Strict license and accreditation procedures impede the market growth
4.4.2 High cord blood banking fee in private UCB banks
4.5 Impact Analysis of Market Restraints
.
.
.
Browse more details with complete TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=320897
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
No comments:
Post a Comment